The Lycopodium Ltd (ASX: LYL) share price is in focus today after the company posted full-year FY26 results with revenue of $377.5 million and NPAT of $40.2 million, both within the guidance range.
Image source: Getty Images
What did Lycopodium report?
- Revenue of $377.5 million for FY26
- EBITDA of $59.5 million
- Net profit after tax (NPAT) of $40.2 million
- Earnings per share (EPS) of 101.1 cents
- Fully franked final dividend of 37 cents per share (full-year dividend 59 cps, up 69% on FY25)
- Healthy cash balance of $106.2 million at 30 June 2026
What else do investors need to know?
Lycopodium delivered results within its February 2026 guidance, and the Board declared a final fully franked dividend, taking the full-year payout ratio to 60%. The company also reported $661 million in committed contracts heading into FY27, highlighting a robust project pipeline.
The company's regional model – with hubs in APAC (Perth), the Americas (Toronto), and Africa (Cape Town) – is producing new opportunities, including increased Americas project activity and expanded presence in Latin America via its SAXUM acquisition. The African hub continues to deliver significant projects, while APAC maintains steady work, notably in Western Australia.
Lycopodium logged zero lost time injuries from 9 million controlled service hours, pointing to a strong safety culture. Key project wins during the year included major works in gold and lithium, and several new contracts are set to ramp up into FY27.
What did Lycopodium management say?
Managing Director & CEO Peter De Leo said:
FY26 has been another successful year for the Company, with an expanded geographic reach and the continued delivery of high-quality studies and projects for our clients globally.
What's next for Lycopodium?
Looking ahead, Lycopodium has issued FY27 guidance for revenue between $540–$580 million and NPAT of $54–$58 million, aiming for a 10% NPAT margin. Management expects a more regionally balanced project portfolio as new work is secured, especially in the Americas and Africa.
Alongside strong resources and infrastructure pipelines, recent contract awards are expected to boost earnings, with further updates promised at the AGM in November. Continued geographic diversification and service expansion underpin the group's strategy for sustained growth.
Lycopodium share price snapshot
Over the past 12 months, Lycopodium shares have risen 54%, outperforming the All Ordinaries Index (ASX: XAO), which has risen 1% over the same period.
